RVLP
Barclays’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,697
| Closed | -$16K | – | 4527 |
|
|
2023
Q1 | $16K | Sell |
13,697
-9,620
| -41% | -$11.2K | ﹤0.01% | 4031 |
|
|
2022
Q4 | $26K | Buy |
23,317
+20,468
| +718% | +$22.8K | ﹤0.01% | 3978 |
|
|
2022
Q3 | $6K | Buy |
+2,849
| New | +$6K | ﹤0.01% | 4354 |
|
|
2021
Q4 | – | Sell |
-2,425
| Closed | -$7K | – | 3934 |
|
|
2021
Q3 | $7K | Sell |
2,425
-2,684
| -53% | -$7.75K | ﹤0.01% | 3807 |
|
|
2021
Q2 | $15K | Sell |
5,109
-5,825
| -53% | -$17.1K | ﹤0.01% | 3785 |
|
|
2021
Q1 | $36K | Buy |
10,934
+6,515
| +147% | +$21.5K | ﹤0.01% | 3580 |
|
|
2020
Q4 | $17K | Sell |
4,419
-1,596
| -27% | -$6.14K | ﹤0.01% | 3398 |
|
|
2020
Q3 | $32K | Sell |
6,015
-682
| -10% | -$3.63K | ﹤0.01% | 3415 |
|
|
2020
Q2 | $46K | Buy |
6,697
+3,753
| +127% | +$25.8K | ﹤0.01% | 3419 |
|
|
2020
Q1 | $9K | Sell |
2,944
-5,282
| -64% | -$16.1K | ﹤0.01% | 3505 |
|
|
2019
Q4 | $57K | Buy |
8,226
+4,174
| +103% | +$28.9K | ﹤0.01% | 3564 |
|
|
2019
Q3 | $15K | Sell |
4,052
-4,516
| -53% | -$16.7K | ﹤0.01% | 3874 |
|
|
2019
Q2 | $33K | Buy |
8,568
+5,810
| +211% | +$22.4K | ﹤0.01% | 3911 |
|
|
2019
Q1 | $10K | Buy |
+2,758
| New | +$10K | ﹤0.01% | 4011 |
|